{
    "2018-05-18": [
        [
            {
                "time": "2018-01-02",
                "original_text": "Congo's Ebola not an international emergency, can be controlled -WHO",
                "features": {
                    "keywords": [
                        "Ebola",
                        "international emergency",
                        "controlled",
                        "WHO"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-03",
                "original_text": "Notable Friday Option Activity: ICPT, JNJ, CELG",
                "features": {
                    "keywords": [
                        "Option Activity",
                        "ICPT",
                        "JNJ",
                        "CELG"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-04",
                "original_text": "Pharma Stock Roundup: Zoetis to Buy Abaxis, NVS Gets FDA Nod for Migraine Drug",
                "features": {
                    "keywords": [
                        "Zoetis",
                        "Abaxis",
                        "NVS",
                        "FDA",
                        "Migraine Drug"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-05-17",
                "original_text": "Eli Lillyâ€™s Valuation on May 17",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Valuation"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-05",
                "original_text": "Johnson & Johnson scraps Alzheimer's trials on safety concerns",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "Alzheimer's",
                        "trials",
                        "safety concerns"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-06",
                "original_text": "Dow 30 Stock Roundup: Walmart, Cisco, Home Depot Beat on Earnings",
                "features": {
                    "keywords": [
                        "Dow 30",
                        "Walmart",
                        "Cisco",
                        "Home Depot",
                        "Earnings"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "retail",
                        "technology",
                        "home improvement"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-07",
                "original_text": "US birth rates hit record low and diaper, baby bottle companies are feeling the pinch",
                "features": {
                    "keywords": [
                        "US birth rates",
                        "record low",
                        "diaper",
                        "baby bottle companies"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "consumer goods"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-08",
                "original_text": "Why J&J's Stock May Plunge 10%",
                "features": {
                    "keywords": [
                        "J&J",
                        "Stock",
                        "Plunge"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}